Landscape of rapid diagnostic tests for severe bacterial infections in advanced HIV Disease
The health products manufacturers support platform: Enhancing regional manufacturing of health technologies in Africa
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Novel business models for accessible monoclonal antibodies for infectious diseases in LMICS: Multistakeholder meeting recommendations
Unitaid and medical oxygen
Universal Health Coverage
Pandemic prevention, preparedness and response
Equitable access to therapeutics for pandemic preparedness and response
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Biomarkers for acute febrile illness at the point-of-care in low-resource settings. Meeting report
Accelerating access to innovative point-of-care HIV diagnostics: Lessons learned from UNICEF
Innovative delivery systems for paediatric medicines technology landscape
Disease Narrative for hepatitis C
Disease narrative for tuberculosis
Disease Narrative for malaria
Disease Narrative for HIV
Hepatitis C diagnostics technology landscape – May 2019
Unitaid and the Government of Spain
About Unitaid (Saving lives faster)
Unitaid and the UK Government
Unitaid audited financial report for the year ended 31 December 2023
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Unitaid audited financial report for the year ended 31 December 2022
HIV/AIDS medicines and pipeline overview
Malaria diagnostics market landscape
HIV/AIDS diagnostics technology landscape – semi-annual update
Tuberculosis medicines technology landscape
ACT Forecasting Update Q2-2012
Tuberculosis diagnostics technology landscape
HIV/AIDS diagnostics technology landscape – 2nd edition
Policy Brief ACT Forecasting
